KKR health­care vet Jim Mom­tazee jump starts a new in­vest­ment firm; Bay­er signs up a top Chi­na biotech play­er to $645M deal

A year af­ter Jim Mom­tazee stepped out of his lead role in charge of health­care for pri­vate eq­ui­ty gi­ant KKR, it’s time for the big re­veal on what he’s been work­ing on.

This morn­ing Mom­tazee un­veiled Pa­tient Square Cap­i­tal, which he says is “be­ing pur­pose-built to be­come the pre­em­i­nent in­vest­ment firm in health­care.”

Noth­ing small about that. And KP­MG vet Maria Walk­er is com­ing in as part­ner and CFO of Pa­tient Square.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER